Mindwalk Holdings Corp. income statement
In fiscal 2026, Mindwalk Holdings Corp. reported revenue of $11.3m, up 47.8% on the year before and net income of −$10.1m. Every line below comes from the company's 10-K and 10-Q filings; column headings link to the filing.
Income statement
| Fiscal year | 2020Apr 2020 | 2021Apr 2021 | 2022Apr 2022 | 2023Apr 2023 | 2024Apr 2024 | 2025Apr 2025 | 2026Apr 2026 |
|---|---|---|---|---|---|---|---|
| Revenue | 11 | 14 | 15 | 16 | 8 | 8 | 11 |
| Cost of revenue | 5 | 5 | 7 | 7 | 5 | 4 | 5 |
| Gross profit | 6 | 9 | 9 | 9 | 3 | 4 | 7 |
| Research and development | 0 | 2 | 6 | 11 | 3 | 3 | 4 |
| Income before tax | −4 | −5 | −13 | −21 | −24 | −27 | −11 |
| Income tax | −0 | 1 | 1 | −1 | −2 | −3 | −0 |
| Net income | −4 | −6 | −13 | −20 | −19 | −22 | −10 |
| Diluted EPS | — | — | −$0.68 | −$0.81 | −$0.76 | −$0.65 | — |
| Diluted shares (average) | 14m | 16m | 20m | 25m | 26m | 33m | 46m |
Compare with peers
- Surrozen, Inc. income statement
- Relay Therapeutics, Inc. income statement
- Caribou Biosciences, Inc. income statement
- Opus Genetics, Inc. income statement
- Lineage Cell Therapeutics, Inc. income statement
Head to head: HYFT vs SRZNHYFT vs RLAYCRBU vs HYFTHYFT vs IRD
More: Biotechnology stocks compared, Health Care sector, rankings of US companies